Selective EP4 Receptor Antagonism for Osteoarthritis Pain: Emerging Evidence and Future Directions for KF-0210.

Anwar AI, Apgar TL, Hegazi AA, Dolan JL, Corona LM, Kaye AD

Open source

DOI
10.1007/s40122-026-00888-x
Published
2026 Sep 9
Container
Pain and therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40122-026-00888-x,
  title = {Selective EP4 Receptor Antagonism for Osteoarthritis Pain: Emerging Evidence and Future Directions for KF-0210.},
  author = {Anwar AI and Apgar TL and Hegazi AA and Dolan JL and Corona LM and Kaye AD},
  year = {2026},
  journal = {Pain and therapy},
  doi = {10.1007/s40122-026-00888-x},
  url = {https://doi.org/10.1007/s40122-026-00888-x}
}

RIS

TY  - JOUR
TI  - Selective EP4 Receptor Antagonism for Osteoarthritis Pain: Emerging Evidence and Future Directions for KF-0210.
AU  - Anwar AI
AU  - Apgar TL
AU  - Hegazi AA
AU  - Dolan JL
AU  - Corona LM
AU  - Kaye AD
PY  - 2026
JO  - Pain and therapy
DO  - 10.1007/s40122-026-00888-x
UR  - https://doi.org/10.1007/s40122-026-00888-x
ER  - 

APA

AI, A., TL, A., AA, H., JL, D., LM, C., & AD, K. (2026). Selective EP4 Receptor Antagonism for Osteoarthritis Pain: Emerging Evidence and Future Directions for KF-0210.. Pain and therapy. https://doi.org/10.1007/s40122-026-00888-x

Source records